{
    "clinical_study": {
        "@rank": "78769", 
        "arm_group": {
            "arm_group_label": "LAGB & LGCP", 
            "arm_group_type": "Experimental", 
            "description": "All study patients will have the following surgical procedure: Laparoscopic Adjustable Gastric Banding and Gastric Plication (LAGB & LGCP).\nThe percent of Excess Body Weight Loss will be monitored at all post op visits."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this research study is to evaluate whether combining laparoscopic adjustable\n      gastric band (AKA: lap-band surgery, LAGB) and laparoscopic gastric plication (making tucks\n      in the large curve of the stomach with stitches) to lap-band surgery alone will result in a\n      greater loss of excess weight over time. We anticipate that the average percent of excess\n      body weight loss for study subjects will exceed 29% at 12 months."
        }, 
        "brief_title": "Weight Loss & Comorbidity Resolution With LAGB Alone vs. LAGB With Gastric Plication", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Morbid Obesity", 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity, Morbid", 
                "Weight Loss"
            ]
        }, 
        "detailed_description": {
            "textblock": "Laparoscopic Adjustable Gastric Banding when combined with gastric plication will provide\n      lasting weight loss benefits to patients. We are projecting that the percent of Excess Body\n      Weight Loss (% EWL) will be greater in study subjects when compared with our control group\n      with LAGB alone. Furthermore, it is anticipated that the % EWL in study subjects will be\n      similar to patients  who have laparoscopic Roux-En-Y Gastric Bypass."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Body Mass Index (BMI) > 35\n\n          -  Meet ASMBS and NIH criteria for Weight Loss Surgery\n\n          -  ASA Class I - III\n\n          -  Agree to refrain from any type of weight-loss drug (prescription or OTC)or\n             elective procedure that would affect body weight for the duration of the trial.\n\n          -  English speaking & comprehension\n\n          -  Normal mental caliber.\n\n        Exclusion Criteria:\n\n          -  Pregnancy, Cancer, Liver failure or Kidney failure\n\n          -  Previous malabsorptive or restrictive procedures performed for the treatment  of\n             obesity\n\n          -  Scheduled concurrent surgical procedure, with the exception of  liver biopsy\n\n          -  Women of childbearing potential lactating at the time of initial consult or at the\n             time of surgery\n\n          -  Any condition which precludes compliance with the study\n\n          -  History or presence of pre-existing autoimmune connective tissue disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703546", 
            "org_study_id": "11-277A"
        }, 
        "intervention": {
            "arm_group_label": "LAGB & LGCP", 
            "description": "All study patients will have the following surgical procedures: Laparoscopic Adjustable Gastric Band & Laparoscopic Gastric Plication. % Excess Body Weight Loss will be monitored at each post op visit.", 
            "intervention_name": "LAGB & LGCP", 
            "intervention_type": "Procedure", 
            "other_name": "Laparoscopic Adjustable Gastric Band & Gastric Plication"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Morbid Obesity", 
            "Weight Loss Surgery", 
            "Laparoscopic Adjustable Gastric Band", 
            "Laparoscopic Gastric Plication", 
            "Imbrication"
        ], 
        "lastchanged_date": "October 8, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Syosset", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11791"
                    }, 
                    "name": "Syosset Hospital, Center for Bariatric Surgical Specialties"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syosset", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11791"
                    }, 
                    "name": "Syosset Hospital - Center for Bariatric Surgical Specialties, 221 Jericho Turnpike"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Weight Loss & CoMorbidity Resolution With Laparoscopic Adjustable Gastric Band Alone vs. Laparoscopic Adjustable Gastric Band With Gastric Plication", 
        "overall_official": [
            {
                "affiliation": "North Shore LIJ Health System, Syosset Hospital, Center for Bariatric Surgical Specialties", 
                "last_name": "Alan C Geiss, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "North Shore LIJ Health System, Syosset Hospital, Director of Surgery", 
                "last_name": "Robert Ward, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Excess Body Weight is identified pre-operatively and will be monitored during each post operative visit. The percent of Excess Body Weight Loss (%EWL) will be calculated using as a baseline the % Excess Body Weight identified pre-operatively during the subject's initial consult. The change in %EWL at will be calculated at 6 months and 12 months. The %EWL will then be compared to a similar cohort of patients who had the LAGB alone at the same milestones. It is anticipated that study patients' %EWL will be significantly greater.", 
            "measure": "% Excess Body Weight Loss (%EWL)", 
            "safety_issue": "No", 
            "time_frame": "6 months post procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703546"
        }, 
        "responsible_party": {
            "investigator_affiliation": "North Shore Long Island Jewish Health System", 
            "investigator_full_name": "Alan Geiss", 
            "investigator_title": "Director of Bariatric & Advanced Laparoscopic Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "A baseline HgbA1c will be obtained pre-operatively for study patients with a comorbid diagnosis of Type 2 Diabetes. HgbA1C will also be obtained at 6 months and 12 months to evaluate the change from the baseline HgbA1C.", 
            "measure": "HgbA1c", 
            "safety_issue": "No", 
            "time_frame": "12 months post procedure"
        }, 
        "source": "North Shore Long Island Jewish Health System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "North Shore Long Island Jewish Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}